Navigation Links
FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
Date:5/11/2009

eneration products in its class. Arno is also developing two additional drug candidates. AR-12 is a potential first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces the endoplasmic reticulum stress pathway, that received FDA acceptance of its IND in the second quarter of 2009. AR-42, an orally available, targeted inhibitor of the Pan-DAC and Akt pathways received FDA acceptance of its IND in the first quarter of 2009.

For more information on Arno please visit www.arnothera.com.

Forward Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding the timing, progress and anticipated results of the clinical development, regulatory processes, potential clinical trial initiations, potential IND and NDA filings, as well as our strategy, future operations, outlook, milestones, the success of Arno's product development, future financial position, future financial results, plans and objectives of management, are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Arno cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that we make. Such factors include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of our product candidates, our ability to finance the development of our product candidates, regulatory risks, and our reliance on third part
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
2. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
3. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
4. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
7. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
8. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
9. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
10. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
11. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 2014 /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in ... its Mylan-Nitro Spray 0.4 mg/metered dose due to the product ... component. A missing "dip tube" could pose ... patient. This defect may lead patients to believe they are ... access it. Not receiving nitroglycerin could place them at risk ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... 2014 Harwood Feffer LLP ( www.hfesq.com ) ... of PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... breached its fiduciary duties to shareholders or violated the ... the Company disclosed: "On September 11, 2014, [PDL] was ... & Young LLP ("EY"), that it was resigning effective ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... 21, 2011  TriReme Medical, Inc. ("TriReme"), a leading ... complex vascular disease, announced today that it has ... Drug Administration to market its Chocolate PTA balloon ... arteries. Chocolate was developed in collaboration with TriReme,s ...
... ceremony coinciding with the 20th anniversary of Los Angeles ... acquired HIV, the University at Buffalo,s School of Pharmacy ... WAT ) for its donation of a state-of-the-art ACQUITY® ... used to build laboratory capacity and advance research into ...
Cached Medicine Technology:TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 4
(Date:9/21/2014)... September 22, 2014 Dry Face Brushing brings ... 3: , 1) Dry Brushing improves blood circulation and tone, ... exfoliates dead cells, toxins and debris from the skin , ... movement , While Body Brushing can and should be done ... it is more fragile and thinner, it needs less. ...
(Date:9/21/2014)... Clara, CA (PRWEB) September 22, 2014 ... conference it has entered into a joint services agreement ... South Dakota, to deploy the CareSpan Virtual Clinic in ... and Avera eCARE plan to deploy their joint services ... Dakota and Wyoming where Avera eCARE is licensed. The ...
(Date:9/21/2014)... birth of an infant prior to 37 weeks of ... increased over the past two decades. According to ... birth affects nearly 500,000 babies each year, or one ... care has improved survival rates for preterm infants, questions ... of preterm infants. , Research led by Barry M. ...
(Date:9/21/2014)... who smoke, those using e-cigarettes (in addition to traditional ... likely to have quit smoking traditional cigarettes than non-users. ... journal of the American Cancer Society, the findings raise ... cancer patients give up smoking. , Because of the ... should be advised to quit. But the rising use ...
(Date:9/21/2014)... 19, 2014) Instituting a partial smoking ban at ... expired carbon monoxide levels, an indicator of exposure to ... residents, health, according to new research. The University of ... study results last week in the journal Addictive ... United States has fallen to 18 percent among adults, ...
Breaking Medicine News(10 mins):Health News:Gorgeous Skin: 3 Top Benefits of Dry Face Brushing from Sublime Beauty® 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 3Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UTHealth researchers study impact of smoking ban in homeless shelter 2
... may help diagnose heart disease, cancers, HIV and other ... clinical methods. The microsponges are an essential component of ... a new paper in the journal Small . ... Professor in Bioengineering and Chemistry, and his colleagues at ...
... the highest adolescent pregnancy and birth rate among developed countries ... pregnant do not have aspirations of going to college or ... researchers at Women & Infants Hospital of Rhode Island shows ... college and get a good job. Whether or not the ...
... Kathleen Doheny HealthDay Reporter , WEDNESDAY, Feb. 9 ... every day may be cutting down on calories, but they ... suggests. "In our study, we saw a significant increased ... regular soda," said Hannah Gardener, an epidemiologist at the University ...
... Louisville School of Medicine professors recently authored reference works ... use of radiation treatment for childhood cancers and the ... Edward C. Halperin, dean of the school, is co-author ... Dr. Kelly M. McMasters, chair of the Department of ...
... the number of brain injuries and deaths from crashes, appear ... spine injury, new research from Johns Hopkins suggests. "We ... riding a motorcycle can be detrimental during a motorcycle crash," ... professor of surgery at the Johns Hopkins University School of ...
... reliance on coastal waters for food, trade and tourism ... closely monitored to guarantee their future sustainability. ESA,s ... full advantage of the unique capabilities of the Medium ... With a resolution of 300 m, MERIS ...
Cached Medicine News:Health News:Microsponges from seaweed may save lives 2Health News:Microsponges from seaweed may save lives 3Health News:Research: Pregnant teens want to go to college, need support 2Health News:Can Diet Soda Boost Your Stroke Risk? 2Health News:Can Diet Soda Boost Your Stroke Risk? 3Health News:New works by UofL professors provide latest oncology reference guides 2Health News:Motorcycle helmets reduce spine injuries after collisions 2Health News:ESA's sharp eyes on coastal waters 2
... AquaFlow™ Collagen Glaucoma Drainage Device when ... procedure has been proven to significantly ... the complications often associated with penetrating ... medications. As a result, patient outcomes ...
... Control is a device ... a filter between the ... tubing that captures nuclear ... and efficiency of phaco ...
... is an innovative, stat analyzer that measures ... on-board co-oximetry and integrated data management "all ... include pH, PCO 2 , PO 2 ... sodium, potassium, chloride, ionized calcium, ionized magnesium, ...
... Bio-logic has demonstrated continuous innovations in computerized ... first Digital EEG system brings the latest ... VISION is the first Windows XP Pro ... all your EEG needs: epilepsy monitoring, routine ...
Medicine Products: